Atai Life Sciences Net Change in Investments - Total 2020-2025 | ATAI

Atai Life Sciences net change in investments - total from 2020 to 2025. Net change in investments - total can be defined as the total change in long term and short term investments
Atai Life Sciences Annual Net Change in Investments - Total
(Millions of US $)
2024 $N/A
2023 $N/A
2022 $N/A
2021 $-53
2020 $-2
2019 $N/A
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.327B $0.000B
atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $19.694B 19.41
Encompass Health (EHC) United States $12.072B 25.59
DaVita (DVA) United States $10.842B 15.24
Chemed (CHE) United States $8.282B 26.03
Elanco Animal Health (ELAN) United States $6.427B 13.77
Option Care Health (OPCH) United States $5.320B 23.72
RadNet (RDNT) United States $4.521B 286.95
Amedisys (AMED) United States $3.076B 20.69
LifeStance Health (LFST) United States $2.252B 0.00
Addus HomeCare (ADUS) United States $2.022B 22.20
Astrana Health (ASTH) United States $1.517B 37.58
U.S Physical Therapy (USPH) United States $1.189B 30.69
Aveanna Healthcare Holdings (AVAH) United States $1.171B 66.67
Pennant (PNTG) United States $1.014B 37.23
Daxor (DXR) United States $0.036B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.023B 0.00
Ontrak (OTRK) United States $0.007B 0.00
Psychemedics (PMD) United States $0.000B 0.00